Vector Science & Therapeutics Agrees to an Option to Invest in LyoGenesis Plus, Securing Long-Term Access to FDA-Registered, cGMP Manufacturing

Vector Science & Therapeutics (TSXV: PAIN) ("Vector" or the "Company") today announced it has entered into an option agreement to purchase up to a 15% equity interest in LyoGenesis Plus for cash ...

Vector Science and Therapeutics Announces Listing on the TSX Venture Exchange

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this ...

Vector Science & Therapeutics Enters Three-Year Development and Manufacturing Agreement with MPP Group LLC

Vector Science & Therapeutics (TSXV: PAIN) ("Vector" or the "Company") today announced that it has entered into a development and manufacturing agreement with MPP Group LLC ("MPP"), a Mequon, ...

/C O R R E C T I O N -- Vector Sciences & Therapeutics/

In the news release, Vector Science & Therapeutics Enters Three-Year Development and Manufacturing Agreement with MPP Group ...

Vector Science & Therapeutics Expands Board of Directors with Appointment of Dr. Alexander Dobranowski and Scott Kelly

Vector Science & Therapeutics Corp. (TSXV: PAIN) ("Vector" or "Company") today announced the appointment of Dr. Alexander Dobranowski and Scott Kelly to its Board of Directors ("Board"), further ...
Newswire

Vector Science & Therapeutics Announces Tommy Thompson as Chairman of the Board

Former Wisconsin Governor and U.S. Secretary of Health and Human Services Brings Extensive Healthcare Leadership to Pioneer of Transdermal Drug Delivery Technology MEQUON, Wis., April 30, 2026 /CNW/ - ...
BizTimes

Vector Science & Therapeutics agrees to option to invest in LyoGenesis Plus, gaining access to FDA-registered manufacturing facility

Mequon-based Vector Science & Therapeutics announced that it has entered into an option agreement to purchase up to a 15% ...